Transfusion Monitors FY2022.xls

XLS spreadsheet 84 KB Posted Oct 17, 2023

Attached to: 6515--Solicitation Gel Automatic Tests for VA Portland. Vendors submitting quotes must have an active FSS contract.
Solicitation number: 36C26024Q0002
Issued by: Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20

About this file

Written by GovTribe AI · Dec 21, 2023

This document contains a quality control monitor report for a transfusion service at a Veterans Affairs medical center. The report provides monthly and quarterly data on blood utilization and transfusions for fiscal year 2021, including the number of specimens tested, units crossmatched and issued, transfusion reactions, and resources management details. Key metrics monitored include testing volumes, crossmatch to transfusion ratios, appropriateness of transfusion times, and wastage of blood products. The related federal contract opportunity is a solicitation posted to the GSA Schedule for automated testing equipment for the VA medical center's transfusion service laboratory. Vendors must have an active Federal Supply Schedule contract to be eligible to submit a quote in response. The solicitation does not provide pricing or technical requirements for the laboratory equipment sought.

View the file

Other files

File	Type	Posted
36C26024Q0002 0001.docx	DOCX document	Oct 17, 2023
36C26024Q0002.docx	DOCX document	Oct 13, 2023

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

FY Tx Monitors

UTILIZATION MONITORS	FY22	Oct	Nov	Dec	Q1	Jan	Feb	Mar	Q2	April	May	June	Q3	July	Aug	Sept	Q4	FY23
T&S Specimens	3069	247	233	265	745	234	217	254	705	246	220	198	664	213	280	240	733	2847
ABO/Rh Confirmations	596	50	41	39	130	46	53	45	144	44	41	40	125	32	52	48	132	531
Total Specimens	3665	297	274	304	875	280	270	299	849	290	261	238	789	245	332	288	865	3378
Mislabeled Specimens	125	19	5	12	36	9	9	5	23	2	7	5	14	6	13	6	25	98
Crossmatches	5060	409	294	427	1130	243	249	312	804	207	468	225	900	198	285	251	734	3568
Issued Units	3802	319	188	377	884	193	200	253	646	180	419	171	770	215	344	261	820	3120
Returned Units	475	57	39	74	170	26	9	55	90	23	23	33	79	31	43	37	111	450
Emergency Issue Patients	8	1	1	1	3	0	0	2	2	1	2	0	3	0	0	1	1	9
Emergency Issue Units	11	2	2	1	5	0	0	6	6	1	2	0	3	0	0	2	2	16
Emergency Issue Units Transfused	10	2	2	1	5	0	0	6	6	1	2	0	3	0	0	1	1	15
Liver Transplants	20	1	2	3	6	1	2	3	6	0	1	1	2	0	1	2	3	17
Cancelled Liver Transplants	22	2	2	0	4	2	0	1	3	0	0	0	0	0	1	0	1	8
General Medicine
Crossmatches	1060	122	48	69	239	45	40	53	138	51	359	47	457	91	80	139	310	1144
Transfusions	861	71	43	59	173	39	36	37	112	49	342	40	431	70	67	115	252	968
C:T Ratio	1.2	1.7	1.1	1.2	1.4	1.2	1.1	1.4	1.2	1.0	1.0	1.2	1.1	1.3	1.2	1.2	1.2	1.2
MICU
Crossmatches	655	48	16	78	142	98	57	101	256	48	6	27	81	40	16	14	70	549
Transfusions	478	34	15	62	111	63	42	77	182	44	3	15	62	30	14	11	55	410
C:T Ratio	1.4	1.4	1.1	1.3	1.3	1.6	1.4	1.3	1.4	1.1	2.0	1.8	1.3	1.3	1.1	1.3	1.3	1.3
Outpatient
Crossmatches	1146	75	74	93	242	63	72	88	223	60	52	44	156	67	73	62	202	823
Transfusions	800	39	40	60	139	43	53	48	144	30	25	25	80	31	51	35	117	480
C:T Ratio	1.4	1.9	1.9	1.6	1.7	1.5	1.4	1.8	1.5	2.0	2.1	1.8	2.0	2.2	1.4	1.8	1.7	1.7
All Transfusion
Crossmatches	5060	409	294	427	1130	243	249	312	804	207	468	225	900	198	285	241	724	3558
Transfusions	3325	262	150	302	714	169	190	197	556	156	398	137	691	134	204	145	483	2444
C:T Ratio	1.5	1.6	2.0	1.4	1.6	1.4	1.3	1.6	1.4	1.3	1.2	1.6	1.3	1.5	1.4	1.7	1.5	1.5
Hemolyzed Specimens
CT
UTILIZATION MONITORS	FY21	Oct	Nov	Dec	Q1	Jan	Feb	Mar	Q2	April	May	June	Q3	July	Aug	Sept	Q4	FY22
Component Transfusions
Leukocyte Reduced RBCs	1934	159	114	177	450	129	142	132	403	89	66	104	259	124	191	134	449	1561
Leukocyte Red. + Irrad. RBCs	294	13	14	11	38	11	10	13	34	10	10	6	26	9	14	12	35	133
Washed / Deglyced RBCs	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	108	0	1	4	5	0	1	0	1	0	0	0	0	0	0	0	0	6
Pre treated to prevent GVHD PPH	370	28	11	34	73	10	10	12	32	5	6	9	20	22	16	45	83	208
FP	557	58	9	70	137	14	24	40	78	50	305	13	368	28	70	29	127	710
Cryoprecipitate pools	71	4	0	7	11	3	4	1	8	2	0	14	16	3	10	4	17	52
APPROPRIATENESS REVIEW
Transfused Units (all products)	3336	262	149	303	714	167	191	198	556	156	387	146	689	275	390	330	995	2954
Infusion Time > 4 hours	5	0	0	0	0	0	1	0	1	1	0	0	1	0	0	0	0	2
Infusion Time > 30 min	347	12	26	17	55	25	19	13	57	13	4	12	29	17	21	25	63	204
% > 30 min	10.4	4.6%	17.4%	5.6%	7.7%	15.0%	9.9%	6.6%	10.3%	8.3%	1.0%	8.2%	4.2%	6.2%	5.4%	7.6%	6.3%	6.9%
Infusion Time > 60 min	67	4	3	4	11	5	2	2	9	2	0	6	8	1	1	3	5	33
% > 60 min	2	1.5%	2.0%	1.3%	1.5%	3.0%	1.0%	1.0%	1.6%	1.3%	0.0%	4.1%	1.2%	0.4%	0.3%	0.9%	0.5%	1.1%
MONITORS	FY21	Oct	Nov	Dec	Q1	Jan	Feb	Mar	Q2	April	May	June	Q3	July	Aug	Sept	Q4	FY22
SUMMARY OF PATIENT TRANSFUSION REACTIONS
# of Patients	14	1	1	2	4	0	3	1	4	3	1	0	4	0	3	2	5	17
Leukocyte Reduced RBCs	13	2	2	2	6	0	2	1	3	2	0	0	2	0	3	1	4	15
Leukocyte Red. + Irrad. RBCs	2	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	2
Washed / Deglyced RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-treated to prevent GVHD PPH	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
FP	3	0	0	0	0	0	1	0	1	1	0	0	1	0	0	0	0	2
Cryoprecipitate pools	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Not Assoc. with Specific Unit	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Suspected Disease Transmission	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SUMMARY OF ERRORS AND OTHER EVENTS
Incorrect Unit Released - Not Transfused	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Incorrect Unit Released - Transfused	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Incorrect Patient Transfused	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Incorrect Product Released - Not Transfused	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Incorrect Product Released - Transfused	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Errors and/or Events	22	1	1	3	5	1	1	1	3	0	1	0	1	0	0	0	0	9
Planned Deviations	10	0	0	0	0	0	0	1	1	0	0	0	0	1	0	1	2	3
RESOURCES MANAGEMENT	FY21	Oct	Nov	Dec	Q1	Jan	Feb	Mar	Q2	April	May	June	Q3	July	Aug	Sept	Q4	FY22
Number of Units Received From Blood Product Supplier (American Red Cross)
Leukocyte Reduced RBCs	2009	184	120	182	486	162	182	141	485	106	103	116	325	128	191	172	491	1787
Leukocyte Red. + Irrad. RBCs	306	11	14	13	38	9	15	10	34	11	12	6	29	12	14	12	38	139
Washed / Deglyced RBCs	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	134	0	2	4	6	1	2	0	3	0	0	0	0	0	0	0	0	9
Pretreated to prevent GVHD PPH	395	39	20	37	96	20	17	29	66	14	16	13	43	25	18	48	91	296
FP	778	72	40	50	162	20	20	55	95	59	310	20	389	60	70	50	180	826
Cryoprecipitate pools	76	3	2	7	12	3	4	0	7	3	0	11	14	9	13	0	22	55
Total Units Received	3700	309	198	293	800	215	240	235	690	193	441	166	800	234	306	282	822	3112
Number of Prospective Lookback Units Identified by Blood Product Supplier (American Red Cross)
Units Identified	5	1	0	0	1	0	1	1	2	0	0	0	0	0	0	0	0	3
Returned to ARC / Expired	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Discarded	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0
Other*	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0
Transfused	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1
Physician Notified	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0
RESOURCES MANAGEMENT	FY21	Oct	Nov	Dec	Q1	Jan	Feb	Mar	Q2	April	May	June	Q3	July	Aug	Sept	Q4	FY22
Units Credited by Blood Product Supplier (Transfer, Return, Recall, Broken, etc.)
Leukocyte Reduced RBCs	48	5	8	8	21	0	0	0	0	0	0	0	0	0	0	15	15	36
Leukocyte Red. + Irrad. RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Washed / Deglyced RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	16	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-treated to prevent GVHD PPH	12	8	6	1	15	0	0	0	0	0	0	0	0	2	2	1	5	20
FP	57	0	0	0	0	0	0	1	1	1	0	0	1	1	0	0	1	3
Cryoprecipitate pools	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1
Outdated Units (Wasted → Units reached their original outdate)
Leukocyte Reduced RBCs	14	1	0	0	1	0	0	10	10	13	35	14	62	17	11	9	37	110
Leukocyte Red. + Irrad. RBCs	6	0	0	1	1	0	0	0	0	0	2	0	2	0	0	0	0	3
Washed / Deglyced RBCs	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	13	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1
Pre-treated to prevent GVHD PPH	11	2	3	1	6	7	2	3	12	2	3	3	8	3	2	1	6	32
FP	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cryoprecipitate pools	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Units Discarded Prior to Original Outdate (Wasted → Thawed and not used, Returned Over Time/Temp, Punctured, etc.)
Leukocyte Reduced RBCs	22	3	1	8	12	1	0	1	2	2	2	0	4	0	0	0	0	18
Leukocyte Red. + Irrad. RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Washed / Deglyced RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Autologous WB/RBCs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
PPH	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-Treated to prevent GVHD PPH	1	1	0	0	1	0	0	2	0	2	0	1	3	0	0	0	0	4
FP	146	15	6	16	37	4	5	15	24	1	1	2	4	20	2	13	35	100
Cryoprecipitate pools	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1

&LPathology and Laboratory Medicine Service VA Portland Health Care System Portland, Oregon&C &"Arial,Bold"&12Transfusion Service Quality Control Monitors

FY 2021&RFY2021

&L&8

38 USC 5705, HSRO/QA Confidential&C

Page &P of &N Viers, Eva (Portland):

Unit received by OHSU in error. Withdrawal forwarded to OHSU.

Mislabeled Specimens Hemolyzed Specimens

Infusion Time > 60 min

File details come from the government source that posted it. Updated Oct 17, 2023.